Top analysts on stock perps · Analyst
Andrew Degasperi (Exane BNP Paribas): analyst track record on stock perps
Andrew Degasperi of Exane BNP Paribas on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars3.7★
Success53%
Excess return+5.0%
rank#3,365
Ratings155
ratings on stock perps18
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 16 | 35 |
| Stock | 15 | 27 |
| Buy / hold / sell | 9 / 7 / 0 | 24 / 8 / 3 |
| Upgrades / downgrades / initiations | 5 / 2 / 8 | 6 / 2 / 18 |
| Price targets hit / missed | 8 / 8 (50%) | 16 / 19 (46%) |
| Avg. return after a rating (TipRanks) | +1.7% | +0.6% |
| Best / worst call | +49.4% / -19.8% | +71.9% / -75.2% |
After buy calls: not enough measured cases yet
Current calls on stock perps
Recent ratings
- Sep 24, 2026 $SNPS: Upgraded · Hold · $420 · article
- Sep 24, 2026 $SNPS: Upgraded · Hold · $420 · article
- Jun 18, 2026 $PTC: Initiated · Hold · $130 · article
- Jun 18, 2026 $ADSK: Initiated · Buy · $295 · article
- May 11, 2026 $HUBS: Downgraded · Hold · $210 · article
- Jan 15, 2026 $IOT: Upgraded · Buy · $40.00 · article
- Oct 2, 2025 $SNPS: Initiated · Sell · $425 · article
- Oct 2, 2025 $CDNS: Initiated · Buy · $400 · article
- Sep 10, 2025 $VEEV: Reiterated · Buy · $320 · article
- Jun 12, 2025 $DDOG: Reiterated · Buy · $150 · article
- Jun 6, 2025 $IOT: Maintained · Hold · $38.00 · article
- May 21, 2025 $PANW: Reiterated · Buy · $220 · article
- Apr 28, 2025 $ZS: Upgraded · Buy · $260 · article
- Apr 22, 2025 $HUBS: Initiated · Buy · $700 · article
- Oct 8, 2024 $PANW: Initiated · Buy · $205 · article
- Sep 6, 2023 $TEAM: Reiterated · Hold · $170 · article
- Jul 26, 2023 $CDNS: Maintained · Buy · $265 · article
- Jun 29, 2023 $TEAM: Initiated · Hold · $150 · article
Andrew Degasperi3.7★ · 53% success · +5.0% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.